Asx Announcement Nature Publication for Cellmid’s Midkine in Cancer
ثبت نشده
چکیده
منابع مشابه
Asx Announcement Midkine Antibodies Effective in Cancer
Since its discovery midkine’s role in cancer has been validated extensively. Approximately 200 peer-reviewed publications have been released on the topic, including four within the last three months. These studies, by multiple research groups around the world, show that MK is a key driver of tumorigenesis in at least 25 different types of cancers, including those of the breast, lung, colorectal...
متن کاملAutomatic Categorization of Announcements on the Australian Stock Exchange
This paper compares the performance of several machine learning algorithms for the automatic categorization of corporate announcements in the Australian Stock Exchange (ASX) Signal G data stream. The article also describes some of the applications that the categorization of corporate announcements may enable. We have performed tests on two categorization tasks: market sensitivity, which indicat...
متن کاملMidkine promoter-based conditionally replicative adenovirus therapy for midkine-expressing human pancreatic cancer
BACKGROUND To develop a novel therapeutic strategy for human pancreatic cancer using a midkine promoter-based conditionally replicating adenovirus. METHODS We examined midkine mRNA expression and midkine protein expression by seven human pancreatic cancer cell lines (AsPC-1, BxPC-3, CFPAC-1, HPAC, MIAPaCa-2, PANC-1, and Suit-2), as well as by non-cancerous pancreatic tissue and pancreatic can...
متن کاملMidkine in plasma as a novel breast cancer marker.
Midkine, a heparin-binding growth factor, is up-regulated in many types of cancer. The aim of this study was to measure plasma midkine levels in patients with breast cancer and to assess its clinical significance. We examined plasma midkine levels in 95 healthy volunteers, 11 patients with ductal carcinoma in situ (DCIS), 111 patients with primary invasive breast cancer without distant metastas...
متن کاملMidkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer
Midkine, a heparin-binding growth factor, has been identified as a promising cancer biomarker. In non-small cell lung cancer (NSCLC), the serum and urine midkine levels have not been intensively investigated. The aim of the present study was to investigate the diagnostic and prognostic potential of serum and urine midkine levels in patients with NSCLC. The serum midkine levels were measured in ...
متن کامل